1. Home
  2. XEL vs NTRA Comparison

XEL vs NTRA Comparison

Compare XEL & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Energy Inc.

XEL

Xcel Energy Inc.

HOLD

Current Price

$72.01

Market Cap

49.9B

Sector

Utilities

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$389.83

Market Cap

47.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XEL
NTRA
Founded
1909
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Medical Specialities
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.9B
47.4B
IPO Year
2003
2015

Fundamental Metrics

Financial Performance
Metric
XEL
NTRA
Price
$72.01
$389.83
Analyst Decision
Buy
Strong Buy
Analyst Count
12
15
Target Price
$89.00
$259.07
AVG Volume (30 Days)
5.0M
1.1M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
2.89%
N/A
EPS Growth
N/A
0.65
EPS
1.82
N/A
Revenue
$11,537,000,000.00
$210,939,000.00
Revenue This Year
$9.77
$18.08
Revenue Next Year
$8.32
$19.65
P/E Ratio
$39.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$71.67
$157.43
52 Week High
$84.23
$373.07

Technical Indicators

Market Signals
Indicator
XEL
NTRA
Relative Strength Index (RSI) 30.12 71.57
Support Level N/A $187.64
Resistance Level $83.15 N/A
Average True Range (ATR) 1.22 10.99
MACD -0.32 2.46
Stochastic Oscillator 1.02 89.36

Price Performance

Historical Comparison
XEL
NTRA

About XEL Xcel Energy Inc.

Xcel Energy manages utilities serving 3.9 million electric customers and 2.2 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan; Public Service Company of Colorado; and Southwestern Public Service Company, which serves customers in Texas and New Mexico. It is one of the largest renewable energy suppliers in the US, with more than half of its electricity sales coming from carbon-free energy.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: